Brought to you by 
Novartis to co-promote Tilak's OdySight medical videogame in France
14 May 2019
Executive Summary
Novartis AG agreed to partner with digital health start-up Tilak Healthcare to exclusively co-promote to ophthalmologists in France the latter's OdySight prescribed therapeutic mobile videogame.
Deal Industry
- Digital Health
- Medical Devices
-
Medical Devices
- Diagnostic Equipment & Supplies
- Monitoring Equipment & Devices
Deal Status
- Final
Deal Type
-
Alliance
- Co-Promotion
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Novartis to co-promote Tilak's OdySight medical videogame in France
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice